Exhibit 99.1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.001 par value per share, of Inovio Pharmaceuticals, Inc. and further agree to the filing of this agreement as an exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.

 

Date: November 16, 2026 TANG CAPITAL PARTNERS, LP  
     
  By: Tang Capital Management, LLC  
  Its: General Partner  
     
  By: /s/ Kevin Tang  
    Name: Kevin Tang  
    Title: Manager  

 

 

TANG CAPITAL PARTNERS INTERNATIONAL, LP

 
     
  By: Tang Capital Management, LLC  
  Its: General Partner  
     
  By: /s/ Kevin Tang  
    Name: Kevin Tang  
    Title: Manager  

 

 

TANG CAPITAL PARTNERS III, INC

 
     
  By: /s/ Kevin Tang  
    Name: Kevin Tang  
    Title: Chief Executive Officer  

 

 

TANG CAPITAL PARTNERS IV, INC

 
     
  By: /s/ Kevin Tang  
    Name: Kevin Tang  
    Title: Chief Executive Officer  

 

  TANG CAPITAL MANAGEMENT, LLC  
       
  By: /s/ Kevin Tang  
    Name: Kevin Tang  
    Title: Manager  
     
  /s/ Kevin Tang  
  Name: Kevin Tang